SMAD2 and diabetic kidney disease: Studies indicate that in STZ-induced DKD models, conditional knockout of Smad2 in fibroblasts using the fibroblast-specific protein-1 (FSP1) promoter significantly reduces renal fibrosis (Loeffler et al., 2018).